Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Primer Autor
Bang, Y. -J.
Co-autores
Ruiz, E. Yanez
Van Cutsem, E.
Lee, K. -W.
Wyrwicz, L.
Schenker, M.
Alsina, M.
Ryu, M. -H.
Chung, H. -C.
Evesque, L.
Al-Batran, S. -E.
Park, S. H.
Lichinitser, M.
Boku, N.
Moehler, M. H.
Hong, J.
Xiong, H.
Hallwachs, R.
Conti, I.
Taieb, J.
Título
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Editorial
ELSEVIER
Revista
ANNALS OF ONCOLOGY
Lenguaje
English
Tipo de Recurso
artículo original
Derecho de Acceso
acceso abierto
Description
This work was supported by Merck KGaA, Darmstadt, Germany, and is part of an alliance between Merck KGaA and Pfizer Inc., New York, NY, USA. Medical writing support was provided by ClinicalThinking, Inc., Hamilton, NJ, USA, and funded by Merck KGaA, and Pfizer Inc. No grant number is applicable.
doi
10.1093/annonc/mdy264
Formato Recurso
pdf
Palabras Claves
pd-l1
avelumab
chemotherapy
gastric cancer
gastro-oesophageal junction cancer
phase iii
Ubicación del archivo
Materias
pd-l1
avelumab
quimioterapia
cáncer gástrico
cáncer de la unión gastroesofágica
fase iii
Disciplinas de la OCDE
Oncología
Farmacología y Farmacia
Otros Temas de Medicina Clínica
Id de Web of Science
WOS:000455165100007
Access Rights
acceso abierto
Derechos de acceso
acceso abierto
Formato
pdf
Título de la cita (Recomendado-único)
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Identificador del recurso (Mandatado-único)
artículo original
Versión del recurso (Recomendado-único)
version publicada
ISSN
0923-7534
Tipo de ruta
dorada
verde
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions